Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis†

Abstract

In patients with three-vessel coronary artery disease, CABG is associated with better survival and less revascularization than PCI using 2nd DES at mid-term results.

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease

“…e relative benefits of CABG versus PCI with stents in terms of outcomes are highly debated, particularly with each advancement in stent design. Currently, the state-of-the-art stent is the second-generation DES, which is thinner and coated with a more biocompatible polymer and new "limus" drugs that allow less inflammation and a lower rate of restenosis Journal of Interventional Cardiology than first-generation DESs [7]. PCI may also be preferred because of its improved early safety profile.…”

“…Several trials have reported that PCI is noninferior to CABG in patients with LM disease [5] or multivessel disease [6]. On the other hand, many trials have suggested that CABG might provide better clinical outcomes than PCI [7].…”

Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG

“…Coronary artery bypass grafting (CABG) effectively treats severe coronary atherosclerotic heart disease (left main trunk and/or triple vessel diseases) and improves symptoms in patients with cardiac insufficiency. Patients receiving CABG treatment have lower mortality rate, rate of major adverse cardiac events (MACE), and rate of target vessel revascularization than those receiving PCI treatment [ 1 , 2 ]. The CABG treatment group also had lower heart failure hospitalization rate over three years compared to the PCI group [ 3 ].…”